Zolltarifnummer 3002590000 80 - andere

Einfuhrkosten für 300259 schätzen

Nur eine Schätzung. Der Zollwert ist der Preis einschließlich Transport und Versicherung bis zur EU-Grenze. Verbrauchsteuern, andere Gebühren und herstellerbezogene Antidumpingzölle sind nicht berücksichtigt. Präferenzsätze gelten nur mit gültigem Ursprungsnachweis. Länderzugehörigkeit und Ausnahmen: TARIC, Stand November 2026.

Ausfuhrmaßnahmen für 3002590000

Was gilt, wenn diese Waren die EU verlassen: Ausfuhrkontrollen, Dual-Use- und andere Genehmigungen, Verbote je Bestimmungsland und die besondere Maßeinheit der Ausfuhranmeldung.

Kontrollen und Dokumente 9

	Bestimmungsland	Start	Zoll / Steuer	Rechtsgrundlage Maßnahmetyp
IR	Iran, Islamic Republic of IR	01-01-2022	Dokument nötig ohne Dokument verboten Details	Regelung0267/12 Restriction on export 476
1008	All third countries 1008	15-11-2025	Dokument nötig ohne Dokument verboten Details	Regelung2003/25 Export authorization (Dual use) 478
ZW	Zimbabwe ZW	19-02-2026	Dokument nötig ohne Dokument verboten Details	Regelung0384/26 Export control 737
1008	All third countries 1008	20-05-2023	Dokument nötig ohne Dokument verboten Details	Regelung0966/23 Export control - CITES 715
BY	Belarus BY	20-07-2025	Dokument nötig ohne Dokument verboten Details	Regelung0765/06 Export control 737
RU	Russian Federation RU	20-07-2025	Dokument nötig ohne Dokument verboten Details	Regelung0833/14 Import/export restriction - Common Military List (CML) goods 738
RU	Russian Federation RU	24-06-2023	Dokument nötig ohne Dokument verboten Details	Regelung0833/14 Export control 767
BY	Belarus BY	25-02-2025	Dokument nötig ohne Dokument verboten Details	Regelung0765/06 Export control 767
CD	Congo, Democratic Republic of CD	28-10-2026	Dokument nötig ohne Dokument verboten Details	Regelung1183/05 Export control 737

Geschichte

Präferenzursprungsregeln für 3002590000

Was eine Ware erfüllen muss, um als Ursprungsware eines Partnerlandes zu gelten und den Präferenzzoll zu erhalten, je Abkommen. Wortlaut der Abkommen auf Englisch.

• EU-Egypt Association Agreement · Ägypten

  EU-Lebanon Association Agreement · Libanon

  EU-Morocco Association Agreement · Marokko

  Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products:

  – Products consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses or unmixed products for these uses, put up in measured doses or in forms or packings for retail sale / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product

  – Other

  – – Human blood / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product

  – – Animal blood prepared for therapeutic or prophylactic uses / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product

  – – Blood fractions other than antisera, haemoglobin, blood globulins and serum globulins / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product

  – – Haemoglobin, blood globulins and serum globulins / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product

  – – Other / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product

• Generalised Scheme of Preferences (GSP, GSP+, EBA) · Armenien, Indien, Kenia, Pakistan, Salomonen, Samoa, Syrien, Vietnam

  EU-Singapore FTA · Singapur

  Pharmaceutical products / or: Manufacture from materials of any heading

• Autonomous Trade Preferences (Western Balkans) · Kosovo

  Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products:

  - Products consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses or unmixed products for these uses, put up in measured doses or in forms or packings for retail sale / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product

  - Other:

  - - Human blood / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product

  - - Animal blood prepared for therapeutic or prophylactic uses / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product

  - - Blood fractions other than antisera, haemoglobin, blood globulins and serum globulins / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product

  - - Haemoglobin, blood globulins and serum globulins / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product

  - - Other / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product

• EU-Canada CETA · Kanada

  A change from within any one of these subheadings or any other subheading.

• EU-Chile Association Agreement · Chile

  Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: — Products consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses or unmixed products for these uses, put up in measured doses or in forms or packings for retail sale / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product — Other — — Human blood / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product — — Animal blood prepared for therapeutic or prophylactic uses / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product — — Blood fractions other than antisera, haemoglobin, blood globulins and serum globulins / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product — — Haemoglobin, blood globulins and serum globulins / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product — — Other / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product

• EU-Colombia/Peru/Ecuador Trade Agreement · Ecuador, Kolumbien, Peru

  Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products:

  Products consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses or unmixed products for these uses, put up in measured doses or in forms or packings for retail sale / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 per cent of the ex-works price of the product

  Other:

  Human blood / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 per cent of the ex-works price of the product

  Animal blood prepared for therapeutic or prophylactic uses / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 per cent of the ex-works price of the product

  Blood fractions other than antisera, haemoglobin, blood globulins and serum globulins / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 per cent of the ex-works price of the product

  Haemoglobin, blood globulins and serum globulins / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 per cent of the ex-works price of the product

  Other / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 per cent of the ex-works price of the product

• EU-Algeria Association Agreement · Algerien

  Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products:

  – Products consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses or unmixed products for these uses, put up in measured doses or in forms or packings for retail sale / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product

  – Other

  – – Human blood / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product

  – – Animal blood prepared for therapeutic or prophylactic uses / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product

  – – Blood fractions other than antisera, haemoglobin, blood globulins and serum globulins / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product

  – – Haemoglobin, blood globulins and serum globulins / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product

  – – Other / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product

• EPA CARIFORUM

  Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: – Products consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses or unmixed products for these uses, put up in measured doses or in forms or packings for retail sale / or: Manufacture from materials of any heading, including other materials of heading No 3002. The materials of this description may also be used, provided their value does not exceed 20 % of the ex-works price of the product – Other: – – human blood / or: Manufacture from materials of any heading, including other materials of heading No 3002. The materials of this description may also be used, provided their value does not exceed 20 % of the ex-works price of the product – – animal blood prepared for therapeutic or prophylactic uses / or: Manufacture from materials of any heading, including other materials of heading No 3002. The materials of this description may also be used, provided their value does not exceed 20 % of the ex-works price of the product – – blood fractions other than antisera, haemoglobin, blood globulins and serum globulins / or: Manufacture from materials of any heading, including other materials of heading No 3002. The materials of this description may also be used, provided their value does not exceed 20 % of the ex-works price of the product – – haemoglobin, blood globulins and serum globulins / or: Manufacture from materials of any heading, including other materials of heading No 3002. The materials of this description may also be used, provided their value does not exceed 20 % of the ex-works price of the product – – other / or: Manufacture from materials of any heading, including other materials of heading No 3002. The materials of this description may also be used, provided their value does not exceed 20 % of the ex-works price of the product

• EU Market Access Regulation (EPA) · Côte d’Ivoire, Ghana, Kamerun, Kenia

  Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products:

  – Products consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses or unmixed products for these uses, put up in measured doses or in forms or packing's for retail sale / or: Manufacture from materials of any heading, including other materials of heading No 3002. The materials of this description may also be used, provided their value does not exceed 20 % of the ex-works price of the product

  – Other:

  – – human blood / or: Manufacture from materials of any heading, including other materials of heading No 3002. The materials of this description may also be used, provided their value does not exceed 20 % of the ex-works price of the product

  – – animal blood prepared for therapeutic or prophylactic uses / or: Manufacture from materials of any heading, including other materials of heading No 3002. The materials of this description may also be used, provided their value does not exceed 20 % of the ex-works price of the product

  – – blood fractions other than antisera, haemoglobin, blood globulins and serum globulins / or: Manufacture from materials of any heading, including other materials of heading No 3002. The materials of this description may also be used, provided their value does not exceed 20 % of the ex-works price of the product

  – – haemoglobin, blood globulins and serum globulins / or: Manufacture from materials of any heading, including other materials of heading No 3002. The materials of this description may also be used, provided their value does not exceed 20 % of the ex-works price of the product

  – – other / or: Manufacture from materials of any heading, including other materials of heading No 3002. The materials of this description may also be used, provided their value does not exceed 20 % of the ex-works price of the product

• EU-Jordan Association Agreement · Jordanien

  Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: - Products consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses or unmixed products for these uses, put up in measured doses or in forms or packings for retail sale / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product - Other - - Human blood / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product - - Animal blood prepared for therapeutic or prophylactic uses / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product - - Blood fractions other than antisera, haemoglobin, blood globulins and serum globulins / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product - - Haemoglobin, blood globulins and serum globulins / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product - - Other / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product

• EU-Japan EPA · Japan

  CTSH; A chemical reaction, purification, mixing and blending, production of standard materials, a change in particle size, isomer separation or biotechnological processing is undergone; MaxNOM 50 % (EXW); or RVC 55 % (FOB).

• EU-Korea FTA · Südkorea

  Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products. / or: Manufacture from materials of any heading

• EU-Central America Association Agreement

  Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products,whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products / or: Manufacture from materials of any heading

• EU-Mexico Global Agreement · Mexiko

  Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: — Products consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses or unmixed products for these uses, put up in measured doses or in forms or packings for retail sale / or: Manufacture from materials of any heading, including other materials of heading No 3002. The materials of this description may also be used, provided their value does not exceed 20 % of the ex-works price of the product — Other: — — Human blood / or: Manufacture from materials of any heading, including other materials of heading No 3002. The materials of this description may also be used, provided their value does not exceed 20 % of the ex-works price of the product — — Animal blood prepared for therapeutic or prophylactic uses / or: Manufacture from materials of any heading, including other materials of heading No 3002. The materials of this description may also be used, provided their value does not exceed 20 % of the ex-works price of the product — — Blood fractions other than antisera, haemoglobin, blood globulins and serum globulins / or: Manufacture from materials of any heading, including other materials of heading No 3002. The materials of this description may also be used, provided their value does not exceed 20 % of the ex-works price of the product — — Haemoglobin, blood globulins and serum globulins / or: Manufacture from materials of any heading, including other materials of heading No 3002. The materials of this description may also be used, provided their value does not exceed 20 % of the ex-works price of the product — — Other / or: Manufacture from materials of any heading, including other materials of heading No 3002. The materials of this description may also be used, provided their value does not exceed 20 % of the ex-works price of the product

• EU-Palestine Interim Association Agreement · Palästina

  Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: - Products consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses or unmixed products for these uses, put up in measured doses or in forms or packings for retail sale / or: Manufacture from materials of any heading, including other materials of heading No 3002. The materials of this description may also be used, provided their value does not exceed 20% of the ex-works price of the product - Other: -- human blood / or: Manufacture from materials of any heading, including other materials of heading No 3002. The materials of this description may also be used, provided their value does not exceed 20% of the ex-works price of the product -- animal blood prepared for therapeutic or prophylactic uses / or: Manufacture from materials of any heading, including other materials of heading No 3002. The materials of this description may also be used, provided their value does not exceed 20% of the ex-works price of the product -- blood fractions other than antisera, haemoglobin, blood globulins and serum globulins / or: Manufacture from materials of any heading, including other materials of heading No 3002. The materials of this description may also be used, provided their value does not exceed 20% of the ex-works price of the product -- haemoglobin, blood globulins and serum globulins / or: Manufacture from materials of any heading, including other materials of heading No 3002. The materials of this description may also be used, provided their value does not exceed 20% of the ex-works price of the product -- other / or: Manufacture from materials of any heading, including other materials of heading No 3002. The materials of this description may also be used, provided their value does not exceed 20% of the ex-works price of the product

• EU-Tunisia Association Agreement · Tunesien

  Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Products consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses or unmixed products for these uses, put up in measured doses or in forms or packings for retail sale / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product Human blood / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product Animal blood prepared for therapeutic or prophylactic uses / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product Blood fractions other than antisera, haemoglobin, blood globulins and serum globulins / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product Haemoglobin, blood globulins and serum globulins / or: Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product

• EU-Viet Nam FTA · Vietnam

  Pharmaceutical products. / or: Manufacture from materials of any heading.

Quelle: Europäische Kommission, Access2Markets (CC BY 4.0, gekürzt). Maßgeblich ist der Text des Abkommens. Access2Markets

Anmerkungen und Erläuterungen zu 3002590000

Quellen: Kombinierte Nomenklatur 2026, Anhang I der Verordnung (EWG) Nr. 2658/87 (CELEX 32025R1926), und die Erläuterungen zur Kombinierten Nomenklatur (CELEX 02019XC0329(02)-20260213). Die Abschnitts- und Kapitelanmerkungen sind rechtsverbindlich, die Erläuterungen sind Auslegungshilfen. EUR-Lex

Beschränkungen und Hinweise für 300259

• Güter mit doppeltem Verwendungszweck Verordnung (EU) 2021/821, Anhang I 30025900

  Gilt nur für einen Teil der Waren unter diesem Code (Rechtsakt nennt 30025900).

  Möglicherweise Dual-Use; Eintrag 1C351 in Anhang I prüfen (Korrelationstabelle unverbindlich)

  Rechtsakt auf EUR-Lex lesen

Nur zur Orientierung. Prüfen Sie den Rechtsakt, bevor Sie sich auf einen Hinweis verlassen; Schwellenwerte, Ausnahmen und Genehmigungen sind nicht vollständig abgebildet. Die Dual-Use-Tabelle ordnet Codes Einträgen der Kontrollliste zu und ist unverbindlich.

EU-Handel 2025 für 300259

Einfuhren aus Drittländern

224,4 Mio. €

164 t

Ausfuhren in Drittländer

218,4 Mio. €

Wichtigste Ursprungsländer nach Einfuhrwert

1. Schweiz 135,1 Mio. €
2. Vereinigte Staaten 57,7 Mio. €
3. Vereinigtes Königreich 25,2 Mio. €
4. Brasilien 1,8 Mio. €
5. China 1,6 Mio. €

KN8-Codes unterhalb dieses Codes: 1. Quelle: Eurostat, Comext, CC BY 4.0, aufbereitet von hscode.info. Vertraulicher Handel ist keinen Codes zugeordnet.

Tarifänderungen für 300259 seit 2016

• Jan. 2022 3002590000 Code eingeführt

Monatlicher Vergleich der TARIC-Auszüge der Europäischen Kommission. Ohne saisonale Einfuhrpreise.

Einfuhrzoll im Vereinigten Königreich für 300259

• 0%

Drittlandszollsätze aller britischen Warencodes unter dieser HS-Unterposition. Quelle: UK Department for Business and Trade, Stand 02.11.2026. Der britische Tarif weicht vom EU-Tarif ab.

Einfuhrumsatzsteuer in der EU

• Belgien 21 %
• Bulgarien 20 %
• Dänemark 25 %
• Deutschland 19 %
• Estland 24 % ggf. 9 %
• Finnland 25,5 %
• Frankreich 20 %
• Griechenland 24 % ggf. 6 %, 13 %
• Irland 23 %
• Italien 22 %
• Kroatien 25 %
• Lettland 21 % ggf. 12 %
• Litauen 21 % ggf. 5 %
• Luxemburg 17 %
• Malta 18 % ggf. 5 %
• Niederlande 21 %
• Österreich 20 %
• Polen 23 %
• Portugal 23 %
• Rumänien 21 % ggf. 11 %
• Schweden 25 %
• Slowakei 23 % ggf. 5 %
• Slowenien 22 % ggf. 9,5 %
• Spanien 21 %
• Tschechien 21 % ggf. 12 %
• Ungarn 27 %
• Zypern 19 % ggf. 5 %

Normalsatz je Mitgliedstaat auf Zollwert, Zoll und Transportkosten bis zum Bestimmungsort. Ermäßigte Sätze hängen oft von Verwendung oder Abnehmer ab und gelten nur, wenn das Land sie für die Ware vorsieht. Quelle: Europäische Kommission, Taxes in Europe Database, Stand 02.11.2026.

Ursprungsregeln

Informationen

HS-Code Struktur

HS-Code Baumstruktur